Hello! I’m 75 years old. In 2018 I underwent treatment for inflammatory breast cancer, BRCA1 positive. In 2003 I’d been treated for a different (yet similar) breast cancer with chemo, lumpectomy, radiation. Now I find out that my treatment caused a few mutations in some bone marrow cells and I have high risk (secondary) MDS. A bone biopsy (to explain my decrease in platelets) revealed mutations in DNMT3A, SF3B1, and TP53. My FISH report specified deletion 5q and trisomy 8. Good news, NO EXCESS BLASTS!
I am in the UCLA system and they are one of several centers of excellence nearby. The week after next I will begin treatment with Azacitidine. My husband will take me for the first treatment at least, as I don’t know how it will affect me. I found a useful article that recommended taking Ondansetron prophylactically, which I will do, so I no longer have that question. But I welcome any additional advice you experienced participants can provide.